Forward Pharma A/S (FWP) |
| 1.95 0 (0%) 12-27 16:00 |
| Open: | 1.94 |
| High: | 2.06 |
| Low: | 1.94 |
| Volume: | 43,354 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | NASDAQ Capital Market |
| Industry: | Biotechnology |
| Sector: | Healthcare |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 3.67 |
| Resistance 1: | 3.14 |
| Pivot price: | 2.73 |
| Support 1: | 2.46 |
| Support 2: | 2.04 |
| 52w High: | 6.2797 |
| 52w Low: | 1.43 |
Forward Pharma A/S does not have significant operations. Previously, it operated as a biopharmaceutical company that focused on developing FP187 proprietary formulation of dimethyl fumarate for the treatment of inflammatory and neurological indications. Forward Pharma A/S was incorporated in 2005 and is headquartered in Copenhagen, Denmark.
Financials
| EPS | -0.271 |
| Book Value | 8.760 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | -3.4 |
| Return on Equity (ttm) | -0.8 |
Company news
Thu, 07 Feb 2019
INSY On A High, KIDS Making Giant Strides, No Stopping APVO, EDIT Uncut - RTTNews
Fri, 03 Feb 2017
Why Forward Pharma A/S Stock Surged 107% in January - The Motley Fool
Tue, 13 Dec 2016
Is Forward Pharma A/S (FWP) A Good Stock to Buy? - Insider Monkey
Thu, 02 Oct 2014
Denmark’s Forward Pharma plans IPO - The Pharma Letter
Tue, 13 Jan 2026
Tue, 13 Jan 2026
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
